ŘIHÁČEK, Ivan, Petr FRÁŇA, Daniel SCHWARZ, Martin PLACHÝ and Miroslav SOUČEK. Losartane and Telmisartane in the Patients with Newly Diagnosed Hypertension and Metabolic Syndrome Effect of One Year of Treatment to Clinical Blood Pressure, 24h Blood Pressure, Metabolic and Anthropometric Parameters. In The 23rd Scientific Meeting of The International Society of Hypertension, Vancouver, 26-30.9.2010. 2010. ISSN 0263-6352.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Losartane and Telmisartane in the Patients with Newly Diagnosed Hypertension and Metabolic Syndrome Effect of One Year of Treatment to Clinical Blood Pressure, 24h Blood Pressure, Metabolic and Anthropometric Parameters.
Name in Czech Losartan a telmisartan u pacientů s čerstvě zjištěnou hypertenzí a metabolickým syndromem, vliv losartanu a telmisartanu na hodnoty kazuálního a 24 hodinového tlaku, na metabolické a antropometrické parametry.
Authors ŘIHÁČEK, Ivan, Petr FRÁŇA, Daniel SCHWARZ, Martin PLACHÝ and Miroslav SOUČEK.
Edition The 23rd Scientific Meeting of The International Society of Hypertension, Vancouver, 26-30.9.2010, 2010.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 3.980
Organization unit Faculty of Medicine
ISSN 0263-6352
Keywords (in Czech) hypertenze; 24 hodinové monitorování TK; telmisartane; losartane; metabolické parametry
Keywords in English hypertensio; 24 hour ambulatory blood pressure monitoring; telmisartane; losartane; metabolic parameters
Changed by Changed by: MUDr. Ivan Řiháček, Ph.D., učo 2313. Changed: 2/2/2011 16:01.
Abstract
Objective: To determine the clinical, 24h blood pressure metabolic and anthropometric effects of once daily dosed sartans. Methods: 57 patients in two groups before and after 1 year of treatment with losartane or telmisartane once daily. Results: smoothness index of losartane plus minus standard error of mean was 1,10 plus minus 0,13 for SBPP, 0,81 plus minus 0,11 for DBP, RDH index of losartane was (24,24,0) for both BP. Smoothness index of telmisartane was 1,00 plus minus 0,11 for SBP, 0,84 plus minus 0,10 for DBP, RDH index of telmisartane was (24,24,0) for SBP and (22,15,1) for DBP. No statistically significant changes heart rate, metabolic and anthropometric parameters. Conclusion: losartane have reasonably better homogenous effect on diastolic BP throughout 24h than telmisartane. There are no changes in metabolic parameters.
Abstract (in Czech)
Cíl: zjistit klinický, 24hodinový TK, metabolické a antropometrické parametry u jedenkrát denně dávkovaných sartanů. Metoda: 57 pacientů ve dvou skupinách před a po roční léčbě. Výsledky: Normalizovaný smoothness index losartanu pro STK plus minus střední chyba průměru byl 1.10 plus minus 0.13, pro DTK 0.81 plus minus 0.11. Normalizovaný smoothness index telmisartanu byl pro STK 0.96 plus minus 0.12, pro DTK 0.80 plus minus 0.12. Populační RDH index losartanu byl pro STK (24.24.0) pro DTK (24.24.0). RDH index telmisartanu byl pro STK (22.17.2) a pro DTK(21.15.2). Závěr: Losartan má lepší 24hodinový efekt na hodnoty TK než telmisartan. metabolické parametry se po léčbě nezměnily.
Links
MSM0021622402, plan (intention)Name: Časná diagnostika a léčba kardiovaskulárních chorob
Investor: Ministry of Education, Youth and Sports of the CR, Early diagnostics and treatment of cardiovascular diseases
PrintDisplayed: 22/7/2024 19:04